Semaglutide Compare Semaglutide Compare
Treatment overview

Mounjaro

This page explains the treatment, then shows provider prices, checks, delivery details, support notes and review dates where available.

Last reviewed: 2026-04-25 Reviewer: Editorial team

Mounjaro is the brand name for tirzepatide, a once-weekly injection used as part of weight-management care when it is clinically suitable. Compare prices by dose, how providers explain assessment, and what they say about delivery, support and follow-up.

Mounjaro overview

Start with the treatment, then compare the service

Mounjaro can affect appetite and fullness, but the provider service still matters. Before relying on a price, check the dose shown, how suitability is assessed, what delivery includes and how follow-up support is explained.

Injection pens and provider comparison notes on a clean clinical desk.
Quick guide

What to understand before comparing Mounjaro prices

It is a weekly injection

Mounjaro is usually taken using a once-weekly injection pen. Follow the instructions and advice given by the prescribing service.

Doses can change over time

Provider tables often show several strengths. The cheapest starter price may not reflect the cost of later doses.

Assessment comes first

Suitability depends on a clinical assessment, medical history, current medicines and the provider’s prescribing process.

Support matters later

Follow-up, side-effect guidance, delivery handling and restart rules can become more important once treatment is underway.

Reading the table

How to read the provider rows

Dose shown

Compare the same dose first. A 2.5mg starter price should not be treated as the same thing as a later higher-dose price.

2.5mg5mg7.5mg+

Listed price and delivery

Check whether delivery is included, whether a discount affects the price, and whether checkout fees could change the total.

PriceDeliveryOffers

Checks and support

Look beyond the price row: online assessment, pharmacy review, ongoing support, continuation policy and restart guidance can all affect the decision.

AssessmentSupportContinuity
Choosing a provider

Cheap is not always the same as suitable

The right provider can depend on where someone is in treatment. Starting, continuing, switching, maintaining or returning after a break can each raise different questions.

Starting

Look for clear assessment steps, starter-dose pricing and practical guidance for first supply.

Continuing

Check higher-dose prices, repeat checks, delivery reliability and how the provider handles ongoing requests.

Maintenance

Later on, continuity, lower-BMI policy and support can matter more than the first-order price.

Restarting

After a treatment gap, providers may need to reassess dose history, current health details and whether restart is appropriate.

Dose prices

Why dose changes affect the monthly cost

Mounjaro provider pages usually show multiple strengths. The starting dose is not a permanent price promise, and a later dose can change both monthly cost and how much support someone may want. Look beyond the first visible number and check the full dose range shown.

Starter stage

Check first-month cost, assessment clarity and how the provider explains getting started.

Dose changes

Check whether the provider explains dose reviews, side-effect support and how questions are handled.

Longer-term use

Check support, maintenance wording, repeat checks and what happens if treatment pauses.

NHS and private access

Keep NHS access and private providers separate

NHS access, private prescribing and online provider comparison are related, but they are not the same question. NHS access is usually about eligibility and local pathway. Private provider comparison is more about assessment quality, price visibility, delivery, support and whether the service explains its limits clearly.

NHS access

Check eligibility, local pathway and whether specialist weight-management support is involved.

Private providers

Check clinical assessment, price transparency, provider registration, delivery handling and support.

More detail

Use WLC for the broad overview and Jaro Compare when you want deeper Mounjaro provider detail.

Safety and suitability

What a useful Mounjaro page should make clear

Area Why it matters What to look for
Suitability Mounjaro is not suitable for everyone. Health questions, current medicines, BMI information and clinical review before treatment is considered.
Side effects People often need practical guidance once treatment starts. Plain-English information on common side effects, warning signs and how to contact the provider.
Delivery Injection pens need appropriate handling. Clear delivery timing, packaging information and what to do if a parcel is delayed, damaged or warm.
Continuation The first order is only one part of treatment. Repeat checks, dose-review wording, support access and what happens after a pause or provider switch.
Specialist detail

Where to go for deeper Mounjaro provider comparison

WeightLossComparison keeps this page focused on the main treatment and provider questions. For deeper Mounjaro-specific pricing, maintenance, restart, support and delivery detail, use the specialist Jaro Compare pages.

Jaro provider table

Compare Mounjaro providers with specialist filters and more detailed provider pages.

Delivery checklist

Review clinical review time, dispatch, courier and temperature-handling questions.

Provider types

Understand price-first, support-focused, maintenance and restart-style services.

Compare related guides

Wegovy guide

Compare another weekly injection before focusing too quickly on provider pages.

Mounjaro vs Wegovy

Use a side-by-side comparison if you are weighing up the two weekly injections.

NHS vs private

Compare access options if your real question is where care should begin.

Provider checks

Use a practical checklist before relying on any online treatment service.

Before you continue

Confirm current details with the provider

Prices, dose availability, delivery terms, eligibility wording and support policies can change. Start with the comparison, then confirm current information directly with the provider or a qualified healthcare professional.

Treatment next step

Move from the treatment page into route and provider checks

Treatment pages work best when they stay connected to public provider wording, route differences, listed prices and the wider semaglutide brand picture.

Source checks

MHRA Glp1 Status

MHRA/GOV.UK explains licensed GLP-1 and related medicines and cautions against illegitimate supply channels.

Checked: 25 April 2026 Confidence: High

Source: GLP-1 medicines: what you need to know - GOV.UK / MHRA

Use cautious language around prescription-only medicines.

View source

NICE Tirzepatide

NICE has technology appraisal guidance for tirzepatide in managing overweight and obesity.

Checked: 25 April 2026 Confidence: High

Source: NICE TA1026 tirzepatide for managing overweight and obesity

Reviewed for NHS access guidance, not private provider ranking.

View source

Source check: Brand role, provider wording, public pricing and availability can change. Confirm current details directly with the provider before taking the next step.